NEO short interest
NeoGenomics Inc. · Healthcare · Medical - Diagnostics & Research · settlement date 2026-09-30
| Shares short | 14,150,681 |
|---|---|
| Change vs prior report | -2,558,782 (-15.3%) |
| Change over six months | +85.9% |
| Days to cover | 5.67 (sector: 3.78) |
| Average daily volume | 2,494,760 |
| Rank in Healthcare | #352 of 922 by days to cover |
NEO short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 14,150,681 | -15.3% | 5.67 | 2,494,760 |
| 2026-09-15 | 16,709,463 | +6.0% | 11.18 | 1,495,156 |
| 2026-08-31 | 15,759,505 | -0.8% | 8.98 | 1,754,202 |
| 2026-08-14 | 15,879,070 | +3.0% | 8.30 | 1,913,336 |
| 2026-07-31 | 15,421,614 | +12.0% | 4.17 | 3,700,667 |
| 2026-07-15 | 13,764,655 | +18.5% | 6.02 | 2,286,776 |
| 2026-06-30 | 11,619,928 | +37.5% | 2.11 | 5,496,219 |
| 2026-06-15 | 8,452,734 | -0.4% | 5.53 | 1,527,459 |
| 2026-05-29 | 8,486,518 | -1.6% | 6.90 | 1,230,791 |
| 2026-05-15 | 8,624,188 | -9.6% | 5.48 | 1,572,538 |
| 2026-04-30 | 9,541,861 | +21.0% | 2.72 | 3,511,066 |
| 2026-04-15 | 7,883,014 | +3.5% | 4.77 | 1,653,841 |
| 2026-03-31 | 7,612,763 | -9.1% | 5.12 | 1,486,083 |
| 2026-03-13 | 8,371,684 | -1.0% | 4.65 | 1,800,442 |
| 2026-02-27 | 8,455,018 | -4.9% | 3.90 | 2,166,199 |
| 2026-02-13 | 8,889,595 | -11.3% | 5.52 | 1,610,895 |
| 2026-01-30 | 10,021,133 | +23.9% | 5.07 | 1,977,550 |
| 2026-01-15 | 8,090,064 | +2.8% | 4.01 | 2,017,605 |
| 2025-12-31 | 7,868,602 | -6.0% | 4.89 | 1,609,090 |
| 2025-12-15 | 8,374,376 | -7.5% | 5.51 | 1,521,030 |
| 2025-11-28 | 9,054,876 | +7.6% | 4.26 | 2,126,986 |
| 2025-11-14 | 8,416,654 | +17.3% | 3.44 | 2,448,873 |
| 2025-10-31 | 7,175,657 | +10.2% | 1.57 | 4,574,652 |
| 2025-10-15 | 6,508,598 | +9.8% | 1.09 | 5,959,646 |
| 2025-09-30 | 5,926,806 | +0.1% | 3.29 | 1,803,098 |
import finzdata as yf
yf.Ticker("NEO").short_interest # every report since 2017
yf.Client().short_interest(["NEO"], start="2018-01-01")Healthcare short interest · NEO price history · Who owns NEO · All short interest